Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families
Sobi has been involved in the development and manufacturing ofrecombinant protein drugssince the technology was first developed more than30 years ago.
We want to make a differenceto people with rare diseases.
By working closely with patients and their relatives we learn about their daily challenges and needs.
Interim report Jan-Mar, 2013
pdf-format, 1.94 MB
Annual Report 2012
pdf-format, 5.12 MB
Full Year Report 2012
pdf-format, 556 KB
Interim report Jan-Sep 2012
pdf-format, 573 KB
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, SwedenPhone: +46 8 697 20 00
© Swedish Orphan Biovitrum AB, 2013